Event Information:
Dates
Dates: September, 25th and 26th, 2024
Location
Basel, Switzerland
Related Models
TransCure bioServices at the 24th Annual Biotech in Europe Forum
We are pleased to announce that our CEO, Sebastien Tabruyn, will be attending the 24th Annual Biotech in Europe Forum on September 25-26, 2024, in Basel, Switzerland.
This prestigious event gathers industry leaders, biotech companies, and investors from around the globe to discuss the latest trends and innovations in the life sciences sector.
Sebastien will be present to showcase TransCure bioServices’ cutting-edge preclinical research services on our humanized mouse models. These models are key tools for advancing drug development in fields such as immuno-oncology, inflammation, and infectious diseases.
Don’t miss the opportunity to meet Sebastien and learn how TransCure bioServices can partner with you to accelerate your preclinical efforts.
For more information about the event, visit: https://www.sachsforum.com/24bef-about.html
Book a meeting with Sebastien Tabruyn:
Attending in person for TransCure BioServices:
Sebastien Tabruyn, PhD, CEO
Sebastien Tabruyn holds a PhD in Molecular Biology from the University of Liege (Belgium). With over 20 years of experience as a Project Leader in worldwide academic research institutes, including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia), and the University of Maastricht (Netherlands), Sebastien joined TransCure bioServices in 2013 to develop the first immune-oncology humanized mouse models. Before taking on the role of CEO, Sebastien served as the company’s Chief Scientific Officer for six years, where he was instrumental in driving scientific excellence and innovation. Sebastien Tabruyn has published more than 35 peer-reviewed publications, primarily focusing on oncology, inflammation, immunity, and angiogenesis. As CEO, Sebastien commits his leadership and vision to the expansion of TransCure bioServices through the successful delivery of its client needs.